KLRK1 and neoplasm: Suppresses anti-tumor immune response, promotes tumorigenesis, blocks NK cells activity, Inhibits T-cells, promotes Tregs, downregulates IL-2, Inhibits NKG2D on CD8+ T-cells, upregulates CD133+